万泰生物全资子公司九价HPV疫苗首次获得批签发证明

Core Viewpoint - Wantai Biological's subsidiary, Xiamen Wantai Canghai Biotechnology Co., Ltd., has received the biological product batch release certificate for its nine-valent human papillomavirus (HPV) vaccine, marking its official market launch [1] Company Summary - Wantai Biological's nine-valent HPV vaccine has been approved for market release, indicating a significant milestone for the company [1]